Careers

Recruitment

ImmVirX is growing the team at its R&D Facility in Newcastle. Keep watching this space for news of roles being offered or feel free contact us at [email protected].

In the News

View our recent news stories

Discover the latest news articles featuring ImmVirX, including research innovations, stories about our people and reports from the latest events.

View All Stories

ImmVirX presents update on Phase 1a/b Clinical Study at Medical Oncology Group of Australia Annual Meeting

August 16, 2024 No Comments

ImmVirX appoints Dr. Oksana Zdanska as Medical Director

April 16, 2024 No Comments

ImmVirX and Innovent Enter into Clinical Trial Collaboration to Investigate the Combination of IVX037 and Sintilimab in Difficult-to-treat Cancers

February 21, 2024 No Comments

Careers

Recruitment

In the News

View our recent news stories

ImmVirX presents update on Phase 1a/b Clinical Study at Medical Oncology Group of Australia Annual Meeting

ImmVirX appoints Dr. Oksana Zdanska as Medical Director

ImmVirX and Innovent Enter into Clinical Trial Collaboration to Investigate the Combination of IVX037 and Sintilimab in Difficult-to-treat Cancers

Join Our Mailing List

Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect

A clinical stage company developing novel oncolytic viruses to create powerful new cancer immunotherapy combinations

Company

© 2020 ImmVirX Pty Ltd • Site by Alex Shafren & Noise